Psychiatry and Neurology, Neurology · Norwich, CT
NPI
1407869019
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
One Towne Park Plaza
Norwich, CT, 06360
Phone (860) 886-1433
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
21,207 services
Medicare patients, 2024
183
Average age 65
Drug cost, 2024
$5.2M
2,911 prescriptions
Company payments, 2025
$77K
From 39 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Derek R Smith was code 99214 (office e&m - established), 130 times for 107 patients. In total Derek R Smith billed 21,207 services in 41 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 130 | 107 | $93.09 | $12K |
| 96365 Intravenous Infusion, Hydration | Office | 49 | 18 | $49.06 | $2,404 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 36 | 14 | $1.96 | $70.65 |
| 96375 Injection Administration | Office | 35 | 11 | $12.51 | $438 |
| 99213 Office E&M - Established | Office | 29 | 29 | $61.26 | $1,776 |
| 99204 Office E&M - New | Office | 28 | 28 | $129.14 | $3,616 |
By year: 2022 $26K for 25,029 services; 2023 $27K for 33,040 services; 2024 $25K for 21,207 services.
Medicare prescription drug claims, 2024
In 2024, the drug Derek R Smith prescribed most often to Medicare patients was Baclofen, with 272 prescriptions and refills. In total Derek R Smith wrote 2,911 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 272 | 540 | 67 | $6,918 |
| Gabapentin Generic | 183 | 356 | 47 | $4,909 |
| Clonazepam Generic | 181 | 299 | 37 | $1,890 |
| Tizanidine Hcl Generic | 136 | 220 | 29 | $1,600 |
| Zonisamide Generic | 123 | 277 | 33 | $1,813 |
| Dalfampridine Er Dalfampridine | 118 | 132 | 13 | $17K |
| Amitriptyline Hcl Generic | 107 | 195 | 20 | $1,245 |
| Tysabri Natalizumab | 78 | 78 | Under 11 | $689K |
| Fingolimod Fingolimod Hcl | 77 | 91 | Under 11 | $359K |
| Nurtec Odt Rimegepant Sulfate | 74 | 74 | 21 | $97K |
| Dimethyl Fumarate Generic | 66 | 78 | Under 11 | $151K |
| Oxcarbazepine Generic | 60 | 90 | Under 11 | $2,922 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 53 | 119 | 22 | $9,322 |
| Levetiracetam Generic | 52 | 88 | 12 | $1,120 |
| Diazepam Generic | 50 | 69 | 13 | $203 |
Brand drugs: 516 claims; generic drugs: 2,395 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Derek R Smith $77K ($77K in general payments such as food, travel and fees) from 39 companies. The largest payer was TG Therapeutics, Inc. with $54K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 39 | $54K |
| Biogen, Inc. BIIB | 29 | $12K |
| EMD Serono, Inc. MRK.DE | 32 | $2,704 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $2,428 |
| Amgen Inc. AMGN | 14 | $574 |
| Novartis Pharmaceuticals Corporation NVS | 30 | $552 |
| Pfizer Inc. PFE | 22 | $493 |
| Abbvie Inc. ABBV | 24 | $490 |
| Lundbeck LLC | 13 | $475 |
| Genentech USA, Inc. ROG.SW | 19 | $457 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.